These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35962369)

  • 1. Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects.
    Papalexi E; Galanopoulos A; Kontis D; Markopoulou M; Balta G; Karavelas E; Panagiotidis P; Vlachos T; Ettrup A
    BMC Psychiatry; 2022 Aug; 22(1):548. PubMed ID: 35962369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of vortioxetine in elderly patients with major depressive disorder in real-world clinical practice: Results from the RELIEVE study.
    Di Nicola M; Adair M; Rieckmann A; Christensen M C
    J Psychopharmacol; 2024 Jul; 38(7):615-623. PubMed ID: 39077889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study.
    Almeida SS; Christensen MC; Simonsen K; Adair M
    J Psychopharmacol; 2023 Mar; 37(3):279-288. PubMed ID: 36377523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice: French Cohort Results from the Global RELIEVE Study.
    Polosan M; Rabbani M; Christensen MC; Simonsen K; Ren H
    Neuropsychiatr Dis Treat; 2022; 18():1963-1974. PubMed ID: 36068858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vortioxetine in patients with major depressive disorder and high levels of anxiety symptoms: An updated analysis of efficacy and tolerability.
    Adair M; Christensen MC; Florea I; Loft H; Fagiolini A
    J Affect Disord; 2023 May; 328():345-354. PubMed ID: 36708956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of vortioxetine in patients with major depressive disorder and early-stage dementia: The MEMORY study.
    Christensen MC; Schmidt SN; Grande I
    J Affect Disord; 2023 Oct; 338():423-431. PubMed ID: 37315590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study.
    Chokka P; Bougie J; Proulx J; Tvistholm AH; Ettrup A
    CNS Spectr; 2019 Dec; 24(6):616-627. PubMed ID: 30802419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: A novel dual outcome measure in depressive disorders.
    Christensen MC; Loft H; McIntyre RS
    J Affect Disord; 2018 Feb; 227():787-794. PubMed ID: 29689693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of vortioxetine in patients with major depressive disorder comorbid with generalized anxiety disorder: Results of the RECONNECT study.
    Christensen MC; Schmidt S; Grande I
    J Psychopharmacol; 2022 May; 36(5):566-577. PubMed ID: 35499104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice in Italy: Results from the RELIEVE Study.
    De Filippis S; Pugliese A; Christensen MC; Rosso G; Di Nicola M; Simonsen K; Ren H
    Neuropsychiatr Dis Treat; 2022; 18():1665-1677. PubMed ID: 35971416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Vortioxetine in Working Patients with Major Depressive Disorder in China: A Subgroup Analysis of the RELIEVE China Study.
    Wang G; Si T; Rieckmann A; Ma J; Christensen MC
    Neuropsychiatr Dis Treat; 2024; 20():1211-1223. PubMed ID: 38863483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Taiwanese study on real-world evidence with vortioxetine in patients with major depression in Asia (TREVIDA).
    Yang YK; Chen CS; Tsai CF; Chang CM; Lai TJ; Lee CT; Lin CC; Lan TH; Herr KJ
    Curr Med Res Opin; 2021 Dec; 37(12):2163-2173. PubMed ID: 34515596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Vortioxetine on Emotional Blunting in Patients with Major Depressive Disorder with inadequate response to SSRI/SNRI treatment.
    Fagiolini A; Florea I; Loft H; Christensen MC
    J Affect Disord; 2021 Mar; 283():472-479. PubMed ID: 33516560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world clinical outcomes and treatment patterns in patients with MDD treated with vortioxetine: a retrospective study.
    McDaniel BT; Cornet V; Carroll J; Chrones L; Chudzik J; Cochran J; Guha S; Lawrence DF; McCue M; Sarkey S; Lorenz B; Fawver J
    BMC Psychiatry; 2023 Dec; 23(1):938. PubMed ID: 38093196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and Safety of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: Results from the Single-Arm RELIEVE China Study.
    Wang G; Xiao L; Ren H; Simonsen K; Ma J; Xu X; Guo P; Wang Z; Bai L; Heldbo Reines E; Hammer-Helmich L
    Neuropsychiatr Dis Treat; 2022; 18():1939-1950. PubMed ID: 36065389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of real-world effectiveness of vortioxetine along the treatment algorithm for major depressive disorder.
    Bose R; Hamdani SU; Minhas FA; Herr KJ
    Curr Med Res Opin; 2022 May; 38(5):661-671. PubMed ID: 35049384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder.
    McIntyre RS; Loft H; Christensen MC
    Neuropsychiatr Dis Treat; 2021; 17():575-585. PubMed ID: 33654400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive-functional relationships in major depressive disorder: Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram.
    Levada OA; Troyan AS
    J Affect Disord; 2019 May; 250():114-122. PubMed ID: 30852363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Response to Three Antidepressants in Patients with Major Depressive Episode Who Suffered Covid-19-Related Trauma.
    De Filippis S; Lombardozzi G; Matrone M; Amici E; Trovini G; Perrini F; Di Giovanni A; Giovanetti V; Kotzalidis GD
    Curr Neuropharmacol; 2022 Nov; 20(12):2393-2407. PubMed ID: 35272591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study.
    Mattingly GW; Ren H; Christensen MC; Katzman MA; Polosan M; Simonsen K; Hammer-Helmich L
    Front Psychiatry; 2022; 13():824831. PubMed ID: 35356713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.